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Abstract 29 
Solid organ transplantation is the gold-standard treatment for many with end-organ failure and can 30 
offer a new independence from the burden of disease. However solid organ transplant recipients 31 
(SOTRs) remain at high risk of cardiovascular disease (CVD), poor quality of life and physical 32 
functioning. Increasing physical activity and exercise can improve the health of the general 33 
population, however the effects on those with a transplant remain unclear. Intensive exercise and 34 
sporting activity has the potential to be beneficial, although there remain concerns particularly 35 
around the effects on immune function and the CV system. This review summarises what is known 36 
about the effects of exercise on determinants of health in SOTR and then collates the available 37 
literature investigating the consequences of intensive exercise and sport on the health of SOTR. 38 
There is a paucity of high-quality research, with most evidence being case-studies or anecdotal; this 39 
is understandable given the relatively few numbers of SOTR who are performing sport and exercise 40 
at a high level. However if suitable evidence-based guidelines are to be formed and SOTR are to be 41 
given reassurances that their activity levels are not detrimental to their transplanted organ and 42 
overall health, then more high-quality studies are required.  43 
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Introduction 55 
Solid organ transplantation offers those with end-stage organ disease an intervention which can 56 
transform their lives and is now the gold-standard of care. More patients are successfully 57 
undergoing transplants, partly due to advances in surgical techniques, as well as improvements in 58 
donor recruitment, organ preservation and immunosuppressive therapies. In the UK there has been 59 
a 12% increase in kidney transplants and a rise of 20% from donors after circulatory-death(1). 60 
Worldwide there has been a steady increase in solid organ transplants (SOT) with 114,690 estimated 61 
to have taken place in 2012, however this is meeting <10% of global need, meaning there is 62 
increased emphasis on improving transplant survival(2). Morbidity and mortality following SOT 63 
continues to fall and one-year patient and graft survival from cadaveric transplants has increased 64 
over the last ten years(3). Therefore the long-term focus is on identifying modifiable risk factors 65 
which can be addressed to improve health related quality of life (HRQoL), morbidity and survival.  66 
Exercise has a range of health benefits to the general population including improved HRQoL, 67 
reduced CV risk and chronic inflammation. However there are many other factors which need 68 
consideration such as the effects of immunosuppression, their underlying disease process and 69 
altered body composition which mean that the effects of exercise in the general population cannot 70 
be directly translated into solid organ transplant recipients (SOTRs).  In addition, many SOTRs wish to 71 
either return to, or begin, new sporting activities to improve their health following transplant and 72 
this higher intensity exercise may have more unanticipated effects than activity at lower levels.  73 
Competitive Events 74 
The first Transplant Games were held in the UK in 1978(4) with 99 participants from 5 countries. 75 
Since then there has been a significant growth in the event with emerging evidence of the benefit of 76 
exercise in SOTRs and the publicity surrounding the Games. There are a number of reasons why 77 
SOTRs take up sporting activities or exercise, ranging from perceived health benefits to enjoyment. It 78 
4 
 
can be done simply as a hobby or for social reasons but it can also be life-affirming, a celebration of 79 
regained health, or a way of showing appreciation to their donor and the health services. 80 
The US Transplant Games (USTG) attracts high-level athletes from across the country who have near 81 
age-predicted cardiorespiratory fitness and HRQoL(5). Those more active participants have higher 82 
VO2peakand lower body fat compared to those who train less intensely(6-8). In a paediatric 83 
population, participation at the World Transplant Games (WTG), results in an improvement in 84 
habitual activity, with an increase in those achieving healthy CV fitness, abdominal strength and 85 
upper body strength compared to controls who do not take part(9). 86 
The location of the WTG has been shown to affect rates of organ donation in that local area(10). 87 
Education, awareness and engaging the public through the media have all been shown to increase 88 
knowledge of transplantation and affect willingness to donate. However, donation rates are rarely 89 
maintained after media coverage ceases. 90 
These highly organised events have the potential to greatly improve our knowledge of the effects of 91 
high-intensity exercise on SOTRs and are a potential platform for the development of future 92 
research studies. This review article will summarise the current available literature examining the 93 
effects of physical activity and exercise on SOTRs.  94 
 95 
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Solid Organ Transplantation 101 
Patients with chronic kidney disease (CKD), and those on dialysis in particular, have an elevated CV 102 
risk compared to the general population(11-13). Kidney transplantation improves survival(14), 103 
quality of life(15,16) and reduces CV events(17,18) compared to individuals on dialysis, although 104 
outcomes still remain poorer than in the general population(19), with the rate of cardiac death 10-105 
times higher and the annual rate of fatal or non-fatal CV events 50-times that of the general 106 
population. It is thought that this is due to traditional CV risk factors which remain, such as 107 
hypertension and dyslipidaemia, but non-traditional risks such as immunosuppression(20-22), 108 
chronic inflammation(23,24) and altered haemostasis(25-27) also play an important role.  109 
Patients with severe heart failure, understandably, have elevated morbidity and mortality compared 110 
to the general population. The most common causes of death include congestive cardiac failure 111 
(CCF) and arrhythmias(28). However these numbers have been improving, in part due to the use of 112 
left ventricular assist devices (LVAD) which act to delay or prevent the progression to end-organ 113 
failure(29). Overall outcomes remain better following heart transplant than LVAD so this still remains 114 
the optimum treatment for those with end-stage heart failure(30). Following a heart transplant, 115 
patients have an improvement in survival, QoL and exercise capacity, although these measures often 116 
do not reach those of their non-transplanted counterparts.  117 
Heart transplant recipients (HTRs) represent a complex population, with several issues needing to be 118 
considered when determining their exercise capabilities(31). Prior to transplantation, the donor 119 
heart experiences a significant ischaemic time and then subsequently undergoes reperfusion when 120 
successfully transplanted into the recipient. Also, the anatomy is not completely restored and during 121 
the operation, the heart is surgically denervated and this is not entirely corrected. In the post-122 
operative months, some patients demonstrate signs of partial cardiac re-innervation which may 123 
serve to, in part, normalise their responses to exercise. HTRs also often experience diastolic 124 
dysfunction. The underlying causes are likely to be multi-factorial including hypertension, episodes 125 
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of rejection and vasculopathy of the allograft. These factors directly affect the function of the 126 
transplant and are likely to influence the response to exercise.  127 
For patients with chronic lung conditions, transplantation offers the chance of improving QoL, 128 
morbidity and mortality. In the USA, there are 1572 people currently waiting for a transplant with 129 
the most common underlying diagnoses being congenital disease, chronic obstructive pulmonary 130 
disease (COPD) and cystic fibrosis(32).  131 
Lung transplantation is a highly complex procedure that carries considerable peri- and postoperative 132 
risks. It is a treatment option for patients whose pulmonary function, exercise capacity, and QoL are 133 
drastically restricted and predicted 5-year survival is <50%(33). There are three types of lung 134 
transplant; single lung transplantation (SLTx), double lung transplantation (DLTx) and simultaneous 135 
heart and lung transplantation (HLTx), with the selection depending on the underlying 136 
pathology(34).The 1 and 5-year survival rates for SLTxRs and DLTxRs are 77% and 59% 137 
respectively(35). Infection (38%), rejection (29%), malignancy (15%) and CVD (10.9%) are the main 138 
contributors to morbidity and mortality post-operatively(33) as well as organ specific complications 139 
such as obliterative bronchiolitis, all of which may be influenced by physical activity. Post-transplant 140 
rehabilitation has recently been the focus, in order to optimise long-term outcomes and promote 141 
physical and psychological measures as these still remain impaired despite transplantation(36)with 142 
the majority of lung transplant recipients (LTxRs) remaining sedentary 3-6 months post- 143 
transplant(37).  144 
Liver transplantation (LivTx) offers those with end-stage liver disease improved morbidity and 145 
mortality and is now an established procedure in the developed world, with over 6000 transplants 146 
being performed in the United States in 2010(38). Obesity and the development of metabolic 147 
syndrome are well-recognised after LivTx, with an increasing BMI seen in the first few years after 148 
surgery and 22% of previously normal-weight individuals becoming obese within two years(39). 149 
Independent predictors of obesity include episodes of acute rejection and a higher dose of 150 
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prednisolone. In LivTx recipients (LivTxR), increased BMI at one-year accurately predicts the 151 
development of metabolic syndrome(40) and one-third will have CVD at 8-years. Therefore 152 
addressing weight gain in the early-post-operative period should be seen as a priority to reduce CVD 153 
in the future. LivTx has also been shown to improve markers of QoL including self-reported physical 154 
health, daily activities, general HRQoL and social functioning(41). 155 
 156 
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Cardiovascular System 171 
Regular exercise has positive effects on CV risk in the general population(42), and now the focus has 172 
switched to analysing the effect on transplant recipients.  173 
Renal transplant recipients (RTRs) spontaneously increase their activity levels after transplantation 174 
and this peaks at one-year despite an initial decrease in the first month post-operatively(43)whereas  175 
in the first three months after receiving a heart transplant, HTRs significantly increase their physical 176 
activity levels(44) although the effect plateaus after this time. Those transplant recipients who are 177 
more physically active have reduced CV risk(45) and this principal has been used in the design of 178 
exercise programs aiming to improve a variety of physiological parameters. 179 
Blood Pressure 180 
In RTRs, there are no overall significant effects of exercise on blood pressure (BP)(46,47) with both a 181 
supervised six-week aerobic training and a 1 year home-based aerobic program yielding insignificant 182 
results in those undergoing the intervention (133/87 at baseline to 132/89 at 12 months) compared 183 
to the control group receiving usual care (138/88 to 133/90). Additionally, exercise programs for 184 
RTRs do not seem to interact with anti-hypertensive medications either(48) with the number of anti-185 
hypertensives being similar at all time-points and between groups.  186 
In HTRs, exercise has been shown to have equivocal effects on BP. Some studies of supervised 187 
moderate intensity exercise for 10-12 weeks demonstrate little effect on either systolic or diastolic 188 
BP(49,50) even when combined with strength training(51), with the timing of commencement of the 189 
exercise program after transplantation not influencing outcomes. However, high-intensity interval 190 
training (HIIT) regimes (16-min interval training with intervals of 4-, 2- and 1-min duration at >80% of 191 
VO2peak, separated by a 2-min active rest period) of 12-weeks duration, commenced >12 months 192 
after surgery, significantly reduce systolic BP compared to a control group of exercisers who 193 
continue to do moderate-intensity activity (50). Additionally, one 6-month study of cycle-based 194 
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moderate intensity exercise 5 times-a-week at home, reduced both systolic and diastolic BP in the 195 
exercisers (143/78 at baseline to 121/69 at 6 months) compared to non-exercising controls (140/77 196 
to 136/77), perhaps suggesting that a longer duration of intervention may be needed to have an 197 
effect(52). Hypertension is common in HTRs and beta-blockers have been shown to have an adverse 198 
effect on peak heart rate (HR) during exercise and overall exercise capability(53) therefore their use 199 
needs to be carefully considered in active HTRs. 200 
In LTxRs, a RCT of 3 months of three times-a-week combined aerobic and resistance training(54) led 201 
to a significant improvement in ambulatory 24-hour BP in the intervention group compared to 202 
controls. The exercising group maintained their BP at 1 year after transplantation (129/80 pre-203 
transplant and 126/80 at 1 year) whereas the control group experienced worsening hypertension 204 
(126/73 to 142/89 p<0.01).  205 
Serum Cholesterol 206 
In RTRs, there is no clear consensus as to whether exercise has a beneficial effect on lipid levels as 207 
some studies show an improvement(55) and others do not(47,56-58).  The only study to show an 208 
improvement in total serum cholesterol was based on a Chinese alternative therapy (Don Jeon) for a 209 
duration of 9 weeks with 1 once-a-week supervised session and daily activity at home, unfortunately 210 
the control group of transplanted patients was not equivalent and therefore it is difficult to draw a 211 
meaningful conclusion. The studies which showed no significant improvements in cholesterol 212 
profiles included a variety of interventions including combined exercise program and dietary 213 
advice(56), supervised(57), and home-based exercise(47,58). Additionally there were also variations 214 
in type of exercise with some being solely aerobic(47,59) and others including only 215 
strengthening(57) or a combination of both(58). Interestingly, in one study(57) there was a 216 
significant increase in total cholesterol in both the exercise group (5.55mmol/L to 6.92mmol/L at 5 217 
weeks p=0.001) and the controls (5.40mmol/L to 6.85mmol/L) although this is in part due to a rise in 218 
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HDL-cholesterol (1.29mmol/L to 1.67mmol/L in exercisers vs 1.42mmol/L to 1.51mmol/L in controls 219 
p=0.05). There was no change seen in triglyceride levels.  220 
In LTxRs, the RCT of combined aerobic and resistance training revealed no significant improvements 221 
in total cholesterol (219mg/dL to 191mg/dL at 1 year) compared to controls (169mg/dL to 222 
190mg/dL) or triglycerides (107mg/dL to 159mg/dL vs 86mg/dL to 145mg/dL) (54).  223 
Following LivTx, there is an increase in prevalence of hypertriglyceridaemia and 224 
hypercholesterolaemia after 1-year(60) and metabolic syndrome is very common and has been 225 
described in 44–58% of patients followed for 6 months after transplantation (61).  The development 226 
of metabolic syndrome is associated with lower exercise intensity and older age. In addition exercise 227 
intensity is inversely related to the development of metabolic syndrome after LivTx suggesting that 228 
those who are more active are likely to have improved CV risk factors(62). However an uncontrolled, 229 
supervised 12-week combined aerobic and strength training program with lifestyle counselling(63),   230 
found that there was actually no improvement in lipid profile with total cholesterol:HDL cholesterol 231 
ratio (3.70 to 3.74 after 12-weeks) and LDL cholesterol: HDL cholesterol ratio (2.08 to 2.09) 232 
remaining static. 233 
Glycaemic Control 234 
In RTRs, the total amount of physical activity is significantly lower in RTRs with impaired glucose 235 
tolerance compared to RTRs with normal glucose tolerance (255 vs 580 minutes/week respectively, 236 
P = 0.03) and total physical activity has been identified as an independent predictor of impaired 237 
glucose tolerance in all RTRs (p=0.04)(64). A 6-month study of combined lifestyle modification advice 238 
and 2-hours endurance exercise per week in RTRs(56) with either new-onset diabetes after 239 
transplant (NODAT) or impaired glucose tolerance(IGT) (group 1) versus RTRs with normal glucose 240 
tolerance receiving usual care (group 2)  revealed a 15% improvement in 2-hr postprandial glucose in 241 
group 1 versus 12% deterioration in group 2 (p=0.001). Additionally in group 1, 44% of impaired 242 
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glucose tolerance patients developed normal glucose tolerance, whereas only 4% developed NODAT 243 
and 58% of NODAT patients showed improvement (29% to IGT and 29% to normal). Glucose 244 
metabolism deteriorated in group 2 with 14% developing IGT and 3% developing NODAT. Another 245 
study of strengthening exercise alone(57), commenced within the first few days after 246 
transplantation, showed improvements in glucose levels in both the intervention group (102mg/dL 247 
to 83mg/dL at the end of the study) and the control group (108mg/dL to 83mg/dL) which may reflect 248 
changes in medications (such as decreased steroid doses). 249 
Three months of 3 times-a-week aerobic and resistance training in LTxRs(54) leads to a trend of 250 
reduced rates of overall progression to NODAT (6%) compared to the control group (25%) although 251 
this is not significant (p=0.11) and also a reduction in fasting glucose (99mg/dL to 90mg/dL at 1 year 252 
vs 88mg/dL to 107mg/dL) however again this is not significant (p=0.13). However in LivTxRs, after a 253 
12-week aerobic and strength exercise program, there was actually a trend towards worsening of 254 
glycaemic control (HbA1c 5.40% to 5.60% after the program, p=0.071)(63). 255 
 256 
 257 
 258 
 259 
 260 
 261 
 262 
 263 
 264 
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Body Composition  265 
Body Weight and Soft Tissue 266 
Observational studies have shown that those RTRs who are more physically active have lower 267 
amounts of body fat(65) however a randomised trial of home-based cardiovascular exercise versus 268 
usual care has shown  particularly disappointing effects on body composition(48). In fact body 269 
weight and BMI increase in both groups from baseline (Intervention: 24.8 to 27.7 at 1-year vs 270 
Control: 25.1 to 27.1) and lean body mass remains constant (Intervention: 49.2kg to 49.7kg at 1-year 271 
vs Control: 50.1kg to 51.8kg) whilst fat mass rises (Intervention: 20.8kg to 25.8kg at 1-year vs 272 
Control: 21.2kg to 27.6kg). Increased habitual activity levels do reduce body fat and increase lean 273 
muscle mass in women(66) in some studies but there is no clear link in males. A 7-week isokinetic 274 
bicycle-based program focusing on thigh musculature(67), discovered that RTRs taking prednisolone 275 
and those who were not both benefitted from increased thigh muscle area (Prednisolone group: 276 
128cm2 to 133cm2 p=0.01, Non-prednisolone group: 100cm2 to 107cm2, p=0.005) although there 277 
were non-significant changes in both total fat area and overall thigh area. 278 
Previous CCF and reduced pre-transplantation physical activity both contribute to deterioration in 279 
overall body composition. In HTRs, a 12-week combined aerobic and strength training program 280 
increased total lean tissue mass compared to the control group(51) and 6-months of resistance 281 
exercise training alone also had positive results compared to the control group(68). Fat mass 282 
significantly increased at 2 months after transplant in both the control (+8.3%) and exercising groups 283 
(+7.3%) and 6-months of resistance training restored fat-free mass to levels 3.9% greater than 284 
before transplant (p<0.05). Fat-free mass of the control group decreased progressively to levels that 285 
were 7% lower than pre-transplant values (p<0.05). However HIIT programs have yet to be proven to 286 
be effective in improving body composition(69), with no significant reduction in BMI in the 287 
intervention group (27.2 to 26.5 at follow-up) compared to the controls (26.3 to 26.3 p=0.106) or 288 
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improvement in body fat percentage (Intervention: 26.1% to 25.2% at follow-up versus Control: 289 
24.6% to 25.0% p=0.152).   290 
In LTxRs, a randomised trial of combined aerobic and resistance training did not reveal any positive 291 
effects on body weight or BMI in either the intervention group (22.6 to 24.4 at 1-year) or the 292 
controls (21.5 to 24.1, p=0.89) with both overall body weight and BMI increasing over time in both 293 
groups. 294 
A randomised 10-month home-based aerobic exercise program in combination with dietary advice 295 
has been shown to improve lean body mass, although coincidentally, there were also increases in 296 
body weight, fat-mass and percentage of body fat(70) , additionally there were issues with 297 
adherence to the program, with only 37% following the program as instructed.  When this was taken 298 
into account, total body weight, lean mass, and fat mass increased in all patients over the study 299 
period (p<0.001) with no significant interactions found between the intervention and control groups 300 
in any of the body composition variables.  301 
In LivTxRs, a randomised 24-week combined resistance and aerobic based regime based either at 302 
home or supervised in a clinical setting(71), resulted in a significant increase in BMI in the supervised 303 
exercise group compared to the home-based group and the controls (Supervised: 20.4 to 24.4, 304 
Home-based: 22.3 to 22.6, Control: 22.2 to 22.2 p=0.005). This increase was predominantly due to 305 
an increase in lean mass in the exercising groups (Supervised: 43.4kg to 48.9kg, Home-based: 41.7kg 306 
to 47.0kg, Control: 49.9kg to 45.1kg p=0.009) with a non-significant change in fat mass (Supervised: 307 
13.9kg to 17.5kg, Home-based: 16.4 to 15.6kg, Control: 13.2 to 15.1kg p>0.05). However in another 308 
study(63), 3-months combined training in a supervised group setting, resulted in stabilisation of the 309 
BMI (29.7 to 30.0 after completion, p-=0.287) and a significant reduction in body fat percentage 310 
(33.0% to 31.8%, p=0.049). 311 
 312 
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Bone Mineral Density 313 
 In RTRs, 1-year of home-based aerobic exercise(48) did not influence bone mineral density (BMD) in 314 
either the exercisers (0.970g/cm2 to 0.995g/cm2 at 12 months) compared to the control group 315 
(1.012g/cm2 to 1.024g/cm2, p>0.05). 316 
In HTRs, a 6-month weekly lumbar extensor and twice weekly upper and lower limb resistance 317 
training program(72), found that bone demineralisation occurred early after transplantation, and 318 
BMD losses from compartments with trabecular bone, such as the lumbar spine, were greater than 319 
BMD losses from regions with cortical bone, such as the femoral neck. BMD losses in the lumbar 320 
vertebra were 12% and 15% in the control and training groups, respectively, at 2 months after 321 
transplantation. Following the intervention, losses were significantly reduced compared to the 322 
control group (-3% vs -16%, p<0.05). The main finding of this study was that resistance training was 323 
osteogenic and restored BMD toward pre-transplantation levels in HTRs despite continued 324 
immunosuppression with glucocorticoids. In contrast, regional BMD in the control group did not 325 
indicate any significant recovery toward preoperative levels by 8 months after transplantation. 326 
Additionally, a 6-month resistance training program with calcitonin supplementation versus 327 
calcitonin alone(73), found that total body BMD did not decrease significantly below pre-328 
transplantation values at 2-months after transplantation in either the calcitonin plus training (–0.5%) 329 
or calcitonin reference groups (–1.7%). At 8-months post-transplantation both the calcitonin group 330 
(–2.4%) and the calcitonin plus training group (-2.6%) experienced small but significant (p<0.05) 331 
losses in total body BMD when compared to pre-transplantation values. The magnitude of change in 332 
total body BMD at 2 and 8-months after transplantation were comparable in the two groups. This 333 
suggests that neither calcitonin nor calcitonin plus mechanical loading were efficacious in preventing 334 
small long-term reductions of BMD in non-metabolically active, slow turnover, cortical bone cells of 335 
the appendicular skeleton in HTRs. 336 
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In LTxRs, prior to commencing the training study(74), both the trained (0.63 to 0.54 g/cm2 of 337 
hydroxyapatite) and control groups (0.62 to 0.53 g/cm2 of hydroxyapatite) lost significant and 338 
comparable amounts (-14.5%) of BMD between study entry and 2 months post-transplantation. 339 
After 6-months of weekly lumbar extensor training, the control group lost further lumbar BMD 340 
between 2 and 8 months post-transplantation (0.53 to 0.50 g/cm2 of hydroxyapatite, p<0.05), 341 
decreasing to values that were 19.5% less than pre-transplantation baseline. Lumbar BMD in the 342 
trained group increased significantly (+9.2%) after 6 months (0.54 to 0.60 g/cm2 of hydroxyapatite) 343 
and returned to values that were within 5% of pre-transplantation baseline. The aforementioned 344 
resistance training program, in combination with alendronic acid led to a bigger improvement than 345 
alendronic acid alone(75) . Lumbar BMD decreased significantly to below pre-transplant baseline at 346 
2-months after transplantation in controls (−12.5%), but not in the alendronate (1.5%) or 347 
alendronate + training (1.5%) groups. At 8-months after transplantation, lumbar BMD in controls 348 
was 14.1% below baseline (p<0.05), but was 1.4% above baseline in alendronate recipients (p>0.05). 349 
The alendronate + training group showed a significantly increased lumbar BMD with values 10.8% 350 
greater than before transplant. This indicates that pharmacological intervention should be 351 
prescribed alongside resistance exercise for the greatest benefit in LTxRs.  352 
A 24-week combined resistance and aerobic based regime based either at home or supervised in a 353 
clinical setting for LivTxRs(71) found that total BMD did not change significantly in any group from 354 
baseline to after completion of the program (Supervised: 1.11g/cm2 to 1.11g/cm2, Home-based: 355 
1.21g/cm2 to 1.11g/cm2, Control: 1.21g/cm2 to 1.11g/cm2). However proximal femoral BMD did 356 
differ significantly in the home-based exercise group compared to the controls (Home-based: 0.9 357 
g/cm2 to 0.8 g/cm2, Control: 0.9 g/cm2 to 0.9 g/cm2, p=0.017) although there were no differences in 358 
T or Z-scores. Similarly, a randomised home-based cardiovascular exercise and dietary education 359 
program, found no difference in BMD between the exercisers (1.14 g/cm2 to 1.15 g/cm2) and 360 
controls (1.15 g/cm2 to 1.17 g/cm2). 361 
16 
 
Exercise Capacity 362 
Muscle Strength and Function 363 
In RTRs, a thrice-weekly strengthening focused exercise program of 6 months duration(76), found 364 
that upper extremities muscle strength increased more in the rehabilitation group (15.99 to 18.56 365 
after completion) compared to the control group (15.89 to 16.88) although this did not reach 366 
significance. Similarly, a 7-week isokinetic bicycle-based exercise program investigating outcomes in 367 
those on prednisolone compared to those on steroid-sparing regimes(67), found improvements in 368 
peak torque (at 60°) in both groups (Prednisolone-free: 236Nm to 289Nm after training completion 369 
p<0.005, Prednisolone: 207Nm to 237Nm p<0.005) and in total work output (at 180°/s 370 
(Prednisolone-free: 3563J to 4584J after training completion p<0.001, Prednisolone: 2712J to 3587J 371 
p<0.001). Benefits were also seen in a study of Don Jeon(55), for a duration of 9 weeks with 1 once-372 
a-week supervised session and daily activity at home, where grip strength (p<0.001), back muscle 373 
strength (p=0.01) and sit and reach distance (p<0.001) all improved in the intervention group 374 
compared to those receiving usual care. 375 
In RTRs 1-year of home aerobic training(48), also resulted in an improvement in peak torque (per 376 
body weight) in the intervention group (34.5 ft/lb/kg to 42.5ft/lb/kg) compared to the control group 377 
(33.7ft/lb/kg to 37.2ft/lb/kg, p<0.003). Furthermore, a study of 24-weeks of treadmill exercise 378 
alone(77), revealed that exercise time to exhaustion (12min p<0.001) improved and there were also 379 
large increases seen in isokinetic muscle function in both the quadriceps and hamstrings (p<0.001 to 380 
p<0.0001) although values were still lower than in the untrained non-transplanted healthy control 381 
group. Muscle biopsies showed an unexpected rise in type-2 muscle fibres and low oxidative 382 
capacity suggesting that enhanced muscle contractile function is partly responsible for improved 383 
overall performance. 384 
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In comparison of aerobic training versus resistance training alone in RTRs(78), 12-weeks of twice 385 
weekly supervised exercise found an improvement in the isometric quadriceps muscle force in both 386 
of the exercising groups (Aerobic: 77.9nM to 81.0nM after 12-weeks, Resistance: 91.2nM to 387 
130.3nM) whereas the control group actual deteriorated (101.0nM to 95.1nM), with a significant 388 
difference between the resistance trained group and the controls (p=0.006) A similar pattern was 389 
seen in performance in the sit-to-stand 60 test (Aerobic: 24reps to 27 reps, Resistance: 30reps to 37 390 
reps, Control: 26reps to 26reps) where improvements were seen in both intervention groups in 391 
comparison to the controls although only the difference between resistance training and controls 392 
was significant (p=0.009). 393 
In HTRs, a 6-month study of cycle-based moderate intensity exercise 5 times-a-week at home(52), 394 
found that in the training group, physical performance improved significantly, with exercise time 395 
(7.65mins  to 11.40mins, p<0.01) and maximal workload (75W to 105 W, p<0.01) both improving and 396 
the anaerobic threshold was reached at higher workloads (50 to 75 W). In the control group, physical 397 
performance did not improve with VO2peak (14.33ml/kg/min to 15.60ml/kg/min), exercise time 398 
(8.00mins to 8.50mins) and peak workload (70W to 78W) remaining comparable to baseline. 399 
Another study of 10-weeks of aerobic exercise 2-3 times per week(49), found a significant increase in 400 
peak HR in the exercising group (128bpm to 146bpm) compared to the control group (136bpm to 401 
142bpm, p<0.05) and in duration of the exercise to exhaustion test (Exercisers: 9.2mins to 10.7mins, 402 
Control: 8.5mins to 8.8mins, p<0.05).  403 
A 6-month structured aerobic and strength training program designed for HTRs(79) revealed that 404 
peak workload increased in the exercisers (59W to 94W)  compared to the usual care group (66W to 405 
78W p=0.01) and the duration of exercise performed also improved (Exercisers: 6.9mins to 9.0mins, 406 
Controls:7.2mins to 8.3mins p=0.07).  407 
A study of either moderate exercise or a HIIT regime of 12-weeks duration, commenced >12 months 408 
after heart transplant(50) found improvements between groups in workload achieved (HIIT: 148W to 409 
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162W, Moderate: 155W to 158W, p=0.003) and peak HR (HIIT: 139bpm to 144bpm, Moderate: 410 
140bpm to 141bpm, p=0.027). A second study of HIIT versus usual care(69) also found a significant 411 
improvement in peak HR (HIIT: 159bpm to 163bpm, Control: 154bpm to 153bpm, p=0.035) as well as 412 
the test duration (HIIT: 10.6mins to 14.1mins, Control:12.2mins to 13.0mins p<0.001) and 413 
quadriceps and hamstring strength (HIIT: 394Nm to 402nM, Control: 380nM to 359nM p=0.043). 414 
After LTx, there are significant gains in exercise capacity. In the first 3 months, there is a 60–75% 415 
increase in the distance covered in 6 minute walking test (6MWT), with an ensuing plateau in 416 
performance(80). However VO2maxremains deficient compared to expected levels with a function of 417 
40-60% of predicted achieved(81,82) but there is no overall ventilatory limitation to mild exertion 418 
required for daily living(83). Exercise capacity is reduced in both SLTxRs and DLTxRs(84). LTxRs have 419 
similar thigh muscle volumes, intramuscular fat infiltration and strength of the quadriceps and 420 
hamstrings to those with COPD who have not undergone transplantation. However, quadriceps 421 
endurance tends to be lower in LTxRs compared to people with COPD(85). A 12-week study of 422 
thrice-weekly cycling(86) found that endurance time was improved in LTxRs to the same extent as 423 
healthy subjects but with greater variability between patients (LTxRs: +9min, Healthy Control: 424 
+8min, p<0.05). Additionally, muscle strength significantly improved in LTxRs, with similar increases 425 
also seen in the healthy controls (LTxRs: +4.6kg p = 0.001, Controls: +3.1kg p=0.047), leading to a 426 
recovery of muscle strength as compared with the initial healthy subjects’ value. In LTxRs, there 427 
were also trends to significant changes in the percentage of type I fibre (+7%, p = 0.10) and the type 428 
II fibre diameter (−3μm, p = 0.10).  429 
Three-months of supervised combined aerobic and resistance training(54) resulted in an 430 
improvement in performance in the 6MWT at 1-year in the LTxRs undergoing exercise training 431 
(56%pred to 86%pred) compared to the controls receiving usual care (51%pred to 74%pred p=0.002) 432 
as well as peak workload (Exercisers: 47%pred to 69%pred, Controls: 39%pred to 53%pred, p=0.043) 433 
and quadriceps force (Exercisers: 63%pred to 92%pred, Controls: 56%pred to 71%pred, p=0.001). An 434 
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early intervention of mixed aerobic and strengthening training(87), initiated in the first few weeks 435 
after transplant also reported an improvement in performance in the 6MWT  (451m at 1 month to 436 
543m at 3 months post-transplantation). Improvements between all time points were statistically 437 
significant (p<0.0001), although with no control group for comparison it is difficult to make 438 
assumptions from this study that LTxRs would not have shown improvement after transplant 439 
without the intervention.   440 
In LivTxRs, 10-months of home-based aerobic exercise(70), led to a significant increase in quadriceps 441 
strength in the exercising group over time (26.9ft/lb/weight to 32.6ft/lb/weight p<0.001) although 442 
this was not significantly different to the control group (29.2ft/lb/weight to 32.9ft/lb/weight). 443 
Additionally, after 24 sessions of aerobic treadmill-based exercise(88), the exercising group 444 
increased their walking distance (Baseline: 453.6m to 582.5m after the program p<0.05) compared 445 
to the controls receiving usual care (Baseline 516.5m to 517.7m). 446 
A randomised 24-week combined resistance and aerobic based regime based either at home or 447 
supervised in a clinical setting(71) revealed no significant improvement in performance in the 6MWT 448 
between the supervised exercisers (Baseline: 506.2m to After program: 573.3m), home-based 449 
exercisers (491.2m to 550.5m) or the control group receiving usual care (530.9m to 553.6m p>0.05) 450 
or in the quadriceps strength (Supervised: 506.2Nm to 573.3Nm, Home: 491.2Nm to 550.5Nm, 451 
Control: 530.9Nm to 553.6Nm, p>0.05). However, a supervised 12-week combined aerobic and 452 
strength training program with lifestyle counselling(63) with no control group, did find a non-453 
significant trend towards improvement in quadriceps strength (Baseline 1.3Nm/kg, After program: 454 
1.4Nm/kg p=0.058), although improvements in workload (Baseline 1.6W/kg, After program: 1.7W/kg 455 
p=0.004) and performance in the 6MWT (Baseline: 546.5m, After Program: 578m p=0.004) were 456 
significant.  457 
 458 
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Cardiorespiratory Fitness 459 
In RTRs, a 6-month strengthening program(76), discovered that peak expiratory flow rate (PEF) 460 
increased significantly in those undergoing strength training (Intervention: 419L/min to 516L/min, 461 
Control: 439L/min to 483L/min). One year of home aerobic training(48), also resulted in a significant 462 
improvement in age-predicted VO2 (Intervention: 70.9% to 85.4% at 1-year, Control: 71.6% to 77.4%, 463 
p<0.03) although peak respiratory exchange ratio did not change (Intervention: 1.32 to 1.35, 464 
Control: 1.38 to 1.37 p>0.05). Another study of treadmill exercise alone(77), revealed that exercise 465 
time to exhaustion (12min p<0.001), VO2max (37.5 ml/kg/min p<0.05) and maximum ventilation rate 466 
(68.5L/min p<0.05) all improved. In comparison of resistance or aerobic training versus standard 467 
care(48), VO2max increased over time in all groups (Aerobic: 12.3ml/kg/min to 15.1ml/kg/min, 468 
Resistance: 14.1ml/kg/min to 16.8ml/kg/min, Control: 11.8ml/kg/min to 12.8ml/kg/min) however 469 
significantly greater gains were seen in those who were trained compared to the control group 470 
(Aerobic vs Control p=0.02, Resistance vs Control p=0.002). Nevertheless, in comparison of VO2max 471 
between very well-trained RTRs and non-transplanted controls the transplant patients still have 472 
decreased mechanical efficiency as reflected by an increased VO2/treadmill-speed relationship(89). 473 
Observational studies have found that, even in well-trained HTRs, there were still deficiencies in 474 
VO2max and treadmill speed and the VO2max/treadmill speed relationship compared to healthy 475 
controls(89,90). A 6-month study of cycle-based moderate intensity exercise (52), found that in the 476 
training group, VO2peak improved significantly (14.93ml/kg/min to 19.61ml/kg/min, p<0.001) 477 
compared to the control group (14.33ml/kg/min to 15.60ml/kg/min p<0.05) and this is supported by 478 
a shorter study of 10 weeks duration of aerobic exercise(49) where VO2max also increased to a 479 
greater extent in the exercisers (Intervention: 16.7ml/kg/min to 20.0ml/kg/min, Control: 480 
15.5ml/kg/min to 16.1ml/kg/min, p<0.05). 481 
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Following a 6-month combined aerobic and strength training program(79)it was observed that 482 
VO2peak increased significantly in the intervention group (9.2ml/kg/min to 13.6ml/kg/min) compared 483 
to the controls (10.4ml/kg/min to 12.3ml/kg/min, p=0.01). 484 
HIIT training(50) has been found to be more beneficial in HTRs than moderate aerobic exercise in 485 
improving VO2peak (HIIT: 23.2 to 28.1ml/kg/min, Moderate: 23.0ml/kg/min to 25.6ml/kg/min, 486 
p<0.001). However the respiratory exchange ratio remained unchanged in both the HIIT (1.18 to 487 
1.15) and moderate groups (1.20 to 1.18, p=0.754). These results are supported by another 488 
study(69) of 24-weeks of HIIT training where VO2peak also improved significantly in those in the 489 
intervention group (27.7ml/kg/min to 30.9ml/kg/min) compared to the controls (28.5ml/kg/min to 490 
28.0ml/kg/min, p<0.001) and the respiratory exchange ratio remains stable (HIIT: 1.07 to 1.08, 491 
Control: 1.06 to 1.07, p=0.602). 492 
Following a 12-week, home-based cycling program comparing healthy controls and LTxRs(91), FVC 493 
(Forced Vital Capacity) (LTxRs: 78%pred to 82%pred p=0.19, Controls: 109%pred to 109%pred 494 
p=0.82)  and FEV1 (Forced Expiratory Volume in the first second) (LTxRs 74%pred to 77%pred p=0.44, 495 
Controls: 108%pred to 106%pred p=0.20) remained generally stable in both groups. However VO2max 496 
did show a trend for improvement in the LTxRs (63%pred to 68%pred, p=0.07) and increased 497 
significantly in the healthy controls (101%pred to 113%pred p=0.02). Similarly, a 12-week study of 498 
thrice-weekly home-based aerobic exercise(86) discovered that VO2peak was significantly improved in 499 
healthy subjects after the program, although there was only a trend to improvement observed in 500 
LTxRs (+0.13 ± 0.22, p = 0.059). Additionally, a 6-week part home-based, part-supervised, aerobic 501 
training program(92) found a significant improvement in VO2peak from baseline (18.4ml/kg/min) 502 
compared to after training (20.3ml/kg/min p<0.05), although there were no controls for comparison 503 
therefore is difficult to conclude that the improvements seen were greater than would have been 504 
seen in those receiving usual care.  505 
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Following a supervised mixed aerobic and strength training program of the same duration, VO2max 506 
showed a non-significant improvement compared to the non-exercising controls (Exercisers: 507 
55%pred to 78%pred, Controls: 47%pred to 63%pred, p=0.082) with FEV1 also being non-significant 508 
(Exercisers: 79%pred to 92%pred, Controls: 69%pred to 89%pred, p=0.615). A mixed endurance and 509 
resistance rehabilitation programme (with no control group)(87), completed in the first 12-weeks 510 
post lung-transplant, found that both FEV1 and FVC significantly increased(87) after the training 511 
program (p<0.0001). FEV1 increased from 71% at 1 month to 78% at 2 months and 81% at 3 months. 512 
The improvement from 2 to 3 months was not statistically significant. FVC improved from 69% at 1 513 
month to 77% at 2 months and 81% at 3 months with improvements between each time point being 514 
statistically significant. 515 
Following LivTx, VO2peakincreases by a modest amount(93), however it actually decreases in one-516 
quarter of patients. This persistent impairment of exercise tolerance is principally peripheral in origin 517 
but anaemia and beta-blocker treatment should be considered as major aggravating factors(94). A 518 
randomised 10-month home-based aerobic exercise program in combination with dietary advice(70) 519 
discovered that age-predicted VO2peak increased significantly in the exercising group(71.9%pred to 520 
90.1%pred) compared to the control group receiving usual care (73.2%pred to 83.0%pred p<0.04), 521 
although the respiratory exchange ratio did not change in either group from baseline to 12-month 522 
assessments (Intervention: 1.11 to 1.10 , Control: 1.12 to 1.11 p>0.05). An uncontrolled, supervised 523 
12-week combined aerobic and strength training program with lifestyle counselling(63) also found 524 
that VO2peak increased significantly from baseline (20.9ml/kg/min) to after the intervention 525 
(22.4ml/kg/min p=0.031). 526 
 527 
 528 
 529 
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Quality of Life and Anxiety and Depression 530 
HRQoL describes the subjective assessment of the impact of disease and its treatment across the 531 
physical, psychological and social domains of functioning and well-being(95). There are many factors 532 
of HRQoL including satisfaction with life and individual happiness, as well as objective assessments 533 
of physical and psychological functioning(96). In research studies involving transplant recipients, the 534 
most commonly used method of evaluation of anxiety and depression is the Hospital Anxiety and 535 
Depression Scale (HADS)(97). The HADS is a validated screening instrument for the presence of 536 
depression and anxiety symptoms, which is widely used in hospital settings, it takes less than 5 537 
minutes to complete and has been shown to be acceptable by the population for which it was 538 
designed. The HADS consists of 14 Likert scaled items with two subscales (0–21). Each subscale 539 
includes seven items scored on a four-point scale between 0 and 3. Subscale scores of up to 7 are 540 
considered normal, whereas scores of 8–10 are regarded as borderline and set as clinical 541 
manifestation. Both scales can be interpreted independently from each other. HRQoL is most 542 
commonly measured using the internationally validated SF-36 questionnaire(98). Thirty-six items are 543 
combined into 8 scales such as physical functions (PF, 10 items), social functions (SF, 2 items), role 544 
limitations due to physical problems (RP, 4 items), role limitations due to emotional problems (RE, 3 545 
items), mental health (MH, 5 items), energy and vitality (VIT, 4 items), bodily pain (BP, 2 items), and 546 
a general perception of health (GH, 5 items). The subscales can be combined into two summation 547 
scales measuring the overall physical and mental HRQoL (a physical component summary and a 548 
mental component summary). Sometimes shortened versions of this questionnaire can be use when 549 
time constraints apply (for example SF-12 or SF-8).  550 
HRQoL and Anxiety and Depression following Transplantation 551 
HRQoL often does not improve according to expectations, as RTRs often have ongoing physical and 552 
psychological issues which persist post-operatively.  Diagnoses of psychiatric disorders remain high 553 
with some studies reporting a prevalence of 50% with affective disorders, major depression and 554 
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anxiety being most common at around 5 years post-transplant (99) and those with a cadaveric 555 
transplant are more likely to experience anxiety and depression than those who receive a living 556 
transplant(100). Using the Spielberg State Trait Anxiety Inventory and the Beck Depression Inventory 557 
(BDI), anxiety scores are significantly lower among living transplant recipients (80.2) compared to 558 
cadaveric transplant recipients (86.9, p=0.03). There is also a significant relation between depression 559 
score and kind of graft donation (Living: 11.6, Cadaveric: 16.4, p<0.005). However HRQoL has been 560 
found to improve following renal transplant with a significant improvement in all QoL domains(101). 561 
This improvement occurs within the first 6 months after surgery and remains stable following that. 562 
Predictors of QoL include number of hospital admissions (representing early morbidity after 563 
transplantation), work (representing economic autonomy), and social support. 564 
Following heart transplant, a significant overall improvement in QoL is perceived not only 565 
immediately after the operation(102), but also in the long-term(103). However another study found 566 
that in the immediate post-transplant period there were no significant differences in adjustment, 567 
physical function and employment between HTRs and similar medically managed heart failure 568 
patients(104). The long term improvements(103) are apparent in the physical domain, social 569 
dimension and psychological dimension. The improvement remains stable up to 5 years post-570 
transplant and is not correlated with age, rejection episodes, preoperative medical parameters, or 571 
medication and this is supported by other studies which have also shown improvements in physical 572 
functioning(105,106) and perceived quality of life(107,108) in HTRs. 573 
In the first 3 years after heart transplant, survival analysis indicates that cumulative risks for disorder 574 
onset are major depression, 25.5%; adjustment disorders, 20.8%, post-traumatic stress disorder 575 
(PTSD), 17.0%; and any assessed disorder, 38.3%, with only one case of generalised anxiety 576 
disorder(109). PTSD onset is limited almost exclusively to the first year after transplantation. 577 
Episodes of major depression (but not anxiety disorders) that occur at 8-36 months post-transplant 578 
are more likely than early post-transplant episodes to be treated with psychotropic medications. 579 
Factors increasing cumulative risk for post-transplant psychiatric disorder include a pre-transplant 580 
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psychiatric diagnosis, female gender, longer hospitalisation, more impaired physical functional status 581 
and lower social supports from caregivers or family in the peri-operative period. At around 10 years 582 
post-transplantation moderate or severe depression is still experienced by around 37% of 583 
patients(110), although interestingly around 50% report good or very good satisfaction with QoL and 584 
physical health. However the prevalence of depression is negatively associated with physical domain 585 
(r = −0.45, p<0.01), social domain (r = −0.49, p<0.05), and psychological domain (r = −0.3, p<0.05). 586 
The worst QoL signifies a high prevalence of depression and the subjective assessment of QoL 587 
negatively correlates with the prevalence of depression (r = −0.43; p<0.01). 588 
Within the first 2 years following lung transplantation(111), LTxRs report that several symptoms are 589 
both frequently occurring and rather distressing such as muscle weakness (occurs in 40%, distressing 590 
in 46%, shortness of breath with activity (occurs in 32%, distressing in 36%, and increased hair 591 
growth (occurs in 54%, distressing in 29%).  At around 5 years after lung transplant, patients 592 
demonstrate statistically lower rates of respiratory problems as compared with reference values for 593 
patients with COPD(112). Following completion of the SF-36, in the sub-scales of vitality and mental 594 
health and the mental component summary scale, LTxRs had scores similar to those of the healthy 595 
control population, although the remaining scores were significantly lower. Also, there were no 596 
significant differences between the LTxRs and the reported reference healthy population on the 597 
anxiety and depression sub-scales. However 10% of the patients showed clinical depression and 12% 598 
had clinical anxiety. 599 
Levels of anxiety are higher in those waiting for transplant than in the LivTxR group (7.1 vs 5.6 600 
p<0.05)(113) and the mean score for the depression scale is higher in the waiting group as well (6.5 601 
vs 4.9 p<0.05). Comparing both groups with data from the reference population (mean scores: 602 
anxiety: 4.7, depression: 5.1, total score: 9.9) reveals significant differences for anxiety (p<0.001), 603 
depression (p<0.05) and the summation score (p<0.001). There are also significantly higher scores 604 
for anxiety (p<0.001), depression (p<0.05) and HADS total score (p<0.001) in the group of patients 605 
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on the waiting list compared to the reference population. However after liver transplant, anxiety 606 
scores are significantly higher (p<0.001). 607 
Prior to liver transplantation, half of patients report some level of distress in 14/21 HRQoL 608 
determinants whereas 1-year post-operatively they report distress in only 10/21(114). The most 609 
commonly reported symptoms causing distress at baseline are fatigue and muscle weakness which 610 
are experienced by 98% and 90% respectively, however these are statistically likely to improve at 1-611 
year although 86% remain distressed by fatigue and 79% by weakness demonstrating that these 612 
continue to be a substantial problem for these patients. At baseline the Index of Wellbeing is 8.4 and 613 
this increases to 11.2 at follow-up which is similar to that of the general population (11.8).  Although 614 
wellbeing generally improves it does actually decrease after transplantation in around 15% of 615 
patients. 616 
Exercise and HRQoL and Anxiety and Depression 617 
One study of active RTRs showed that regular exercise significantly improves different aspects of 618 
HRQoL such as social function, general health perception and mental health, compared to their 619 
sedentary counterparts(115). Additionally, just 2 hours of exercise per week significantly ameliorates 620 
RTRs’ self-reported health and fitness condition. The amount of exercise participation also positively 621 
correlates to the patient’s health and fitness condition with no effect on graft function(116). In RTRs, 622 
10-weeks of thrice-weekly cycling has been shown to improve anxiety (HADS score: Baseline: 9.9 623 
After program: 6.0 p<0.004) and depression (HADS score: Baseline 8.3, After program 5.9 p<0.008) 624 
scores in RTRs(117) as well as overall HRQoL as measured by the SF-36 questionnaire (Baseline: 394 625 
After program: 553 p<0.0001) although the authors did not provide a breakdown of the scoring for 626 
each component. A 9-week intervention of Don Jeon, with 1 once-a-week supervised session and 627 
daily activity at home (55), found reductions in both stress (p=0.03) and uncertainty (p=0.001) 628 
compared to the control group and improvements in self-esteem (p<0.001) and overall QoL 629 
(p=0.001) although they do not report which questionnaires have been used. 630 
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After one-year of home-based aerobic exercise(48), the only scale on the SF-36 questionnaire that 631 
approached significant differences between the two groups was the physical functioning scale 632 
(Baseline Exercisers: 68.1, Control: 64.1; 12 months: Exercisers: 84.8, Control: 73.2, P=0.06). 633 
Although both groups improved in the role physical during the 12 months (Baseline Exercisers: 39.0, 634 
Control: 54.9; 12 months: Exercisers: 59.4, Control: 60.6), it remained low compared with the 635 
general population (average for general population is 83). Both groups improved with time in the 636 
physical component summary during the 12 months, (Baseline Exercisers: 40.1, Control: 40.8; 12 637 
months: Exercisers 47.0, Control 44.8, p<0.0001), but there were no significant differences between 638 
the groups as a function of time. At 12 months, both groups were similar to the general population 639 
scores for mental health and the mental component summary; all other scale scores remained lower 640 
than the scores reported for the general population. 641 
A 1-year resistance training intervention for  1 hour twice-a-week, with psychological and dietary 642 
support, specifically designed for obese RTRs (118), found that the mean SF-36 score at 6 months 643 
was significantly higher in the intervention group compared with the control group (583 vs 436 644 
p=.008) and the exercisers had improvements in the domains of vitality (Intervention: 53 to 62, 645 
Control: 59 to 25, p<0.05)  and general health (Intervention:39 to 50, Control: 45 to 29 ,p<0.05) 646 
compared to the controls receiving usual care. This translated positively into job prospects, as 647 
overall, at 12-months there was a significantly higher employment rate of 77.7% in the exercise 648 
group, compared with 12.5% in the control group (p=0.02). 649 
HTRs who participated in an early post-transplant rehabilitation program of supervised cycling or 650 
treadmill-walking for 12 weeks showed a significant increase of SF-36 scores in physical functioning 651 
(59.7 to 77.0), physical role (21.1 to 38.3), bodily pain (57.4 to 73.6), social functioning (63.6 to 72.8), 652 
emotional role (59.2 to 76.3), and mental health (67.1 to 73.4) (119). This study compared the 653 
results to patients undergoing coronary artery bypass grafting (CABG) and found that after early 654 
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post-operative cardiac rehabilitation HTRs showed greater improvement in HRQoL than patients 655 
with CABG regardless of lower physical capacity. 656 
Additionally a hospital-based exercise program of combined aerobic and strength training three-657 
times-a-week over an eight-week period, produced a significant improvement in all aspects of the 658 
SF-36 questionnaire except for  mental health(120), although there was a significant improvement in 659 
depressive symptoms as measured by the BDI (7.36 to 5.86 p<0.05). However there was no change 660 
in symptoms of anxiety as recorded on the Spielberger State-Trait Anxiety Inventory (43.89 to 45.58 661 
p>0.05).  662 
A 24-week HIIT program for HTRs(69) found that both groups had high HRQoL scores and there were 663 
no significant changes in any of the sum-scores. However, there was a significant difference between 664 
the exercisers and the control group on the SF-36 General Health subscale at follow-up (Exercisers: 665 
54 Control: 49, p<0.05). As for subjectively improved health, the exercisers reported 65 on the visual 666 
analogue scale compared to 26 in the control group (p< 0.001). 667 
A 12-week home-based aerobic training program after lung transplantation(86) improved symptoms 668 
of dyspnoea (3.6 to 4.2 after training, p=0.03) and a there was an observed trend towards decreased 669 
fatigue (4.5 to 4.8, p=0.07) as measured by the chronic respiratory questionnaire.   670 
A program for LTxRs within the first 12-weeks post-transplant, of mixed aerobic and strengthening 671 
training(87), revealed that all HRQoL domains improved from month 1 to 3 when measured using 672 
the SF-36. Physical conditioning demonstrated gains up to 3 months (Physical functioning: 46 at 673 
baseline to 75 at 3-months, p<0.05, Role functioning physical: 31 to 71, p<0.05) whereas symptoms 674 
related to surgery for example pain (39 at baseline to 62 at 2-months to 66 at 3-months), showed a 675 
reduction up to 2 months (p<0.05) and then this effect plateaued.  676 
A 3-4 week inpatient intensive rehabilitation program of aerobic and strengthening training for 677 
LTxRs around 4.5 years post-transplantation(121) found no significant improvements in HRQoL (SF-678 
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36) could be demonstrated in the either the exercise group of the usual care group. In fact, the 679 
groups were found to have an already good HRQoL at the first evaluation visit, as indicated by SF-36 680 
scores >80% of 100% best possible and although there was a slight trend toward increased HRQoL 681 
levels, this did not reach statistical significance. 682 
A RCT of 3 months of three times-a-week combined aerobic and resistance training(54) only found a 683 
significant improvement in the physical components of the SF-36 when the intervention group were 684 
compared with controls (Physical functioning: Intervention: 43 at baseline to 77 after 1-year,  685 
Control: 36 to 65 p=0.039. Role functioning physical: Intervention: 31 to 83, Control: 22 to 52 686 
p=0.011). 687 
More physically active LivTxRs have improved general health, physical function, bodily pain and 688 
vitality(122). Fatigue is a common problem following LivTx(123) with 60% perceiving themselves to 689 
be fatigued or severely fatigued. . Following an uncontrolled twice-a-week, 12-week aerobic and 690 
strength rehabilitation program, LivTxRs reported an increase in health-related daily functioning 691 
(Sickness Impact Profile-68, 10.39 to 7.94 p=0.007). When assessing HRQoL with the SF-36 only 692 
physical functioning (67.5 to 75.3 p=0.007) and vitality (7.8 to 58.1 p=0.019) were statistically 693 
significant and the HADS score did not improve for either anxiety (5.5 to 5.4 p=0.929) or depression 694 
(5.8 to 5.4 p=0.432). Furthermore, another uncontrolled, supervised 12-week combined aerobic and 695 
strength training program with lifestyle counselling(63) found that there was a clinically relevant 696 
improvement in fatigue after the intervention (Fatigue Severity Scale 5.5 to 4.9 p=0.014, Visual 697 
Analogue scale 63.5 to 50.3 p=0.043 and Checklist Individual Strength 38.5 to 28.0 p=0.007). 698 
A randomised 10-month home-based aerobic exercise program in combination with dietary 699 
advice(70) found that only the general health aspect of HRQoL improved (SF-36 Intervention: 54.5 to 700 
65.1, Control: 58.8 to 63.0 p<0.05). This indicates that the increase in general health over time is 701 
greater for the exercisers than for those receiving usual care. All other physical scales increased in 702 
both groups (p<0.05) but the change was not significantly different between the exercisers and 703 
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controls. Of the mental scales only mental health showed a significant group by time interaction 704 
(Exercisiers:78.5 to 83.4, Control: 79.3 to 77.9, p=0.009) with the increase being greater over time in 705 
the exercising group. Vitality and social functioning increased in both groups (p<0.001) at 12-706 
months. 707 
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Sporting Performance Following Transplantation 724 
Renal Transplant 725 
High intensity exercise and sport have not been extensively investigated in transplant recipients, 726 
with most publications being case report or small-scale studies.  727 
A study of RTRs, performed at the WTG(124), determined that the average energy expenditure was 728 
3376±739 kcal/day, corresponding to 43.7±13.6 kcal/kg per day, which is 25% higher than those of 729 
age-matched inactive healthy subjects. The transplant recipients were also able to perform activity 730 
at an intensity level greater than three times the resting MET for 197±112 min suggesting that SOTRs 731 
are capable of taking part in sustained moderate-vigorous activity. However the RTRs did perform at 732 
a lower level compared to age-matched best performances of nationally competitive healthy 733 
athletes. Following a complicated post-transplant recovery a previously competitive swimmer has 734 
managed to complete a successful rehabilitation programme and return to swimming(125), taking 735 
part in several WTG and gaining many medals and records. Although transplant patients are 736 
performing at a lower level than healthy athletes, with a structured training program there is 737 
potential for them to return to performance levels which match their non-transplanted counterparts 738 
with adequate training, motivation and nutrition. Another example of a RTR returning to 739 
competition with non-transplanted athletes is seen in a case study of a professional boxer(126). 740 
Within three years of transplantation he had returned to regular training and commenced protein 741 
supplements to improve his body composition. Despite recommendations from physicians he 742 
continued to box professionally and has had no adverse effects to his graft function. 743 
Heart Transplant 744 
A patient, who developed cardiac failure due to dilated cardiomyopathy, underwent a cardiac 745 
transplant(127) and as part of his rehabilitation he was introduced to tennis. At 22-months post-746 
transplant he was able to match the aerobic capacity of an age-matched member of the general 747 
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population. He went on to participate successfully at the WTG and has managed to maintain his 748 
physiological function a decade later at his most recent assessments. Furthermore, an elite cyclist 749 
who experienced heart failure following a myocardial infarction (MI) received a heart transplant 4 750 
months later(128,129). He resumed training after 1 month and underwent maximal exercise testing. 751 
Prior to his MI, his VO2max was 58ml/kg/min, this remained reduced at both 6 and 12-months post-752 
transplant, although there were significant improvements over time. These results imply that if an 753 
individual is physically fit prior to their transplant then this may positively impact on their 754 
subsequent work capacity. In active HTRs it may be beneficial to introduce a more intensive 755 
rehabilitation program so that they can return to competition faster. 756 
It is difficult to predict which patients chronotropic incompetence will affect. A young HTR 757 
experienced a severely reduced exercise capacity with a workload of only 56% predicted(130),with 758 
the major contributor an insufficient HR response to activity. She had a pacemaker implanted and 759 
this significantly improved her physical performance, resulting in her winning several medals at the 760 
European Heart and Lung Transplant Games. This demonstrates that chronotropic incompetence can 761 
be successfully treated and it does not necessarily limit subsequent athletic performance. 762 
Further case-reports have shown that, following an intensive endurance training program, HTRs are 763 
able to improve maximal power, oxygen consumption, resting and submaximal HR and ventilator 764 
anaerobic threshold(131). One such report featured a HTR who completed the Boston marathon in 765 
less than six hours with no observed complications(131) and the second successfully competing for 766 
an intercollegiate conference championship soccer team(132). Additionally, in endurance-trained 767 
HTRs(133), graded exercise does not alter levels of malondialdehyde in either HTRs or healthy 768 
controls and there is also no difference in glutathione peroxidase activity or vitamin E levels 769 
suggesting that exercise to fatigue does not promote an increase in oxidative stress in the blood of 770 
HTRs.  771 
 772 
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Heart and Lung Transplant 773 
A patient with cystic fibrosis successfully underwent a HLTx(134). One year after surgery, exercise 774 
capacity was slightly reduced due to cardio-circulatory rather than ventilatory limitations. In the 10-775 
years after transplantation he took part in strenuous training in order to compete in sports events 776 
for transplant patients. Exercise testing revealed better-than-normal aerobic and ventilatory 777 
capacity as characterized by a noticeably high oxygen uptake, oxygen pulse and delayed onset of 778 
ventilatory anaerobic threshold. This suggests that patients who have had a HLTx are capable of 779 
achieving high levels of physical fitness and can perform well in competitive environments. 780 
Therefore, those patients who are motivated to return to intense physical activity should be 781 
encouraged, as their maximal physical capabilities are often not reached by conventional 782 
rehabilitation.   783 
Sporting Performance in an Extreme Environment 784 
Performance in an extreme environment has been assessed by studying RTRs whilst trekking in the 785 
desert(135). There were minimal differences between transplant and healthy-controls for BP, 786 
hydration status, walking velocity and intensity of physical activity. The selected transplant patients, 787 
who had a creatinine clearance>55ml/min, showed a near-normal physical performance and 788 
acclimatisation to the extreme conditions of the desert environment which suggests that 789 
performance of RTRs can be maintained even in challenging environmental conditions. Moreover, 6 790 
LivTxRs and 15 healthy controls participated in a trek up Mount Kilimanjaro in Tanzania, with an 791 
ascent of 5895m(136). Most of the participants successfully completed the trek (83% LivTxRs vs 792 
84.6% controls). Of those who were unable to complete the climb, the LivTxR reported physical 793 
exhaustion and the two controls developed gastroenteritis and cerebral oedema respectively. 794 
Overall, there was no difference in physical performance, perceived exertion or altitude sickness 795 
between groups. However both experienced reduced oxygen saturations and a rise in BP and HR as 796 
altitude increased. The only significant difference was the development of hypertension in LivTxRs at 797 
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3950m. This study provides evidence that LivTxRs can safely participate in strenuous physical activity 798 
at high altitude, as their adaptive responses are similar to the control participants with few adverse 799 
events seen.  800 
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Risks of Exercise and Sport 817 
There are risks to the transplant recipients of a return to sport, although documented adverse 818 
events are mostly linked to traumatic events. One RTR developed a traumatic lymphocoele following 819 
direct trauma from a squash ball(137) requiring marsupialisation of the lymphocoele in the 820 
peritoneal cavity although the patient recovered fully despite being very unwell initially. 821 
Additionally, following intense gym sessions and heavy lifting, a RTR reported anuria(138). 822 
Investigations revealed a haematoma secondary to a spontaneous pseudocapsular bleed or intense 823 
activity. Following evacuation of the blood clots in theatre, the patient began to pass urine and has 824 
made a full recovery.  825 
Infection remains a concern in transplant recipients and, as exercise can be detrimental to the 826 
immune system, it should be considered when athletes who are already immunosuppressed are 827 
training intensely(139).  After cycling in an 81km event, 10 RTRs and 10 healthy-controls underwent 828 
simulated exposure to pathogens(140). Analysis revealed an oppositional pattern of gene expression 829 
in RTRs compared to controls. In addition, in RTRs several apoptotic genes were over-represented 830 
whereas immune response genes were seen more commonly in controls. RTRs also had a 831 
significantly lower relative increase in neutrophils following the bout of exhaustive exercise(141).  832 
In HTRs, one study discovered that lymphocyte subpopulations do not change during or after a six-833 
week cycling exercise intervention(142),with only slight, non-significant, increases in total T cells, 834 
activated T cells, cytotoxic T cells and the T4+/T8+ ratio. Additionally, levels of immunosuppression 835 
in the bloodstream, episodes of rejection and infections are also unaffected. Another supervised 8-836 
week aerobic program found there is no effect on plasma markers of inflammation (C-reactive 837 
protein, IL-6, TNF-α)(143). However the control group (HTRs receiving usual care) did have a 838 
significant rise in TNF-α following completion suggesting that activity does have a role in improving 839 
inflammation in HTRs.  840 
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Many individuals who receive a SOT, regard it as an opportunity to embark on a new healthier 841 
lifestyle or to re-engage with sporting activities they enjoyed prior to their transplant. There are 842 
many opportunities for SOTRs to partake in competitive sporting events and they are often able to 843 
achieve a fitness level near to that of the general population. Although the intensive training and 844 
exercise that they participate in is usually well-tolerated there are potential issues which may arise 845 
and therefore the benefits of exercise cannot simply be considered as for the general population. 846 
The effects of immunosuppression and the known increase in CV risk means that undertaking 847 
physical training may result in abnormal responses of the immune and CV systems to exercise. Given 848 
the paucity of research, and that it has been highlighted as a top research priority by a panel of 849 
transplantation and sports experts(144), further studies need to be conducted, so that evidence-850 
based guidelines can be produced for this complex population, ensuring the best possible outcomes 851 
whilst limiting adverse events. 852 
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Conclusions and Recommendations 863 
This review explores the benefits of structured exercise programs on the health of SOTRs. 864 
Incorporation of exercise into the routine post-operative care of transplant recipients should be 865 
strongly considered due to the improvement in many aspects of wellbeing in these patients and the 866 
absence of significant complications or side-effects.   867 
Cardiovascular System 868 
Exercise programs of combined aerobic and strength training of at least 3 months duration seem to 869 
be most effective at reducing BP in HTRs and LTxRs, with HIIT being a promising alternative. However 870 
RTRs seem to gain less benefit and this may be in part due to their underlying disease process and 871 
suboptimal renal function. Cholesterol and triglyceride levels do not appear to be augmented by 872 
exercise, with transplant recipients experiencing increases over time regardless of activity. LivTxRs, 873 
who are more likely to experience metabolic syndrome, did however have static total 874 
cholesterol:HDL cholesterol after training and this may represent a slowing of the progression of 875 
hypercholesterolaemia. Glycaemic control in RTRs is improved by a 6-month combined lifestyle 876 
education and endurance exercise program and LTxRs achieve benefit after 3-months of combined 877 
training. However LivTxRs experience worsening of glycaemic control despite 12-weeks of exercise 878 
and this again reflects the complexities of treating those with increased risk of metabolic syndrome, 879 
LivTxRs may benefit from longer interventions or modification of the training program to include 880 
dietary and lifestyle advice.  881 
Body Composition 882 
Both aerobic and combined resistance and aerobic training programs of at least 12-weeks duration 883 
are effective in increasing lean muscle mass, however there are few improvements seen in fat mass 884 
and overall body weight and BMI. Even when dietary advice has been incorporated into the 885 
programs, there have been no additional benefits observed.  BMD decreases in transplant recipients 886 
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post-operatively, predominantly due to immunosuppression and steroids, and this decline is reduced 887 
by targeted lumbar resistance training of at least 6-months duration. The greatest benefit is seen 888 
when combined with alendronic acid, although calcitonin supplementation is not effective. Results 889 
have been less promising in improving femoral BMD and also in LivTxRs, and this requires further 890 
investigation.    891 
Exercise Capacity 892 
Interventions comprising of aerobic or combined aerobic and resistance exercise have consistently 893 
been shown to improve workload and muscle strength. Durations of between 12-weeks and 12-894 
months and both home-based and supervised training have been effective in all types of transplant 895 
recipient. These improvements are also translated into a significant improvement in physical 896 
performance in a variety of tests such as the 6MWT and the capacity to exercise until exhaustion.  897 
In RTRs, HTRs and LivTxRs aerobic, resistance or combined training leads to consistent gains in 898 
aerobic capacity with improvements being seen in home-based and supervised programs and also in 899 
durations of between 10-weeks and 1-year, with frequencies of between 2 and 5 times-a-week. 900 
However LTxRs generally see minimal improvement in FVC, FEV1, VO2max in comparison to transplant 901 
recipients receiving usual care in studies of 12-weeks duration, irrespective of supervision. This is a 902 
reflection of their underlying disease status and they may require longer interventions to see a 903 
benefit. In HTRs, HIIT is more effective than moderate continuous exercise in improving exercise 904 
capacity and this could be a potential area of further investigation in other transplant recipients, 905 
particularly LTxRs.  906 
Quality of Life 907 
The most commonly used measures of HRQoL and anxiety and depression are the SF-36 and HADS 908 
respectively. In general there is an improvement in the overall SF-36 score and in particular physical 909 
functioning, vitality and general health in all types of transplant recipients, with changes being seen 910 
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following supervised, inpatient and home-based exercise of varying types. Measures of mental 911 
health prove more variable, with no clear trend emerging with regards to which type of exercise 912 
intervention is most beneficial. Similarly, when anxiety and depression are assessed, a short 10-week 913 
program of cycling for RTRs significantly improved both anxiety and depression, whereas an 8-week 914 
combined program for HTRs showed only a statistically significant improvement in depressive 915 
symptoms and in LivTxRs, 12-weeks of aerobic and strength training failed to show an improvement 916 
in either anxiety or depression. Structured exercise programs may be useful in improving anxiety and 917 
depression and more importantly they are not detrimental to mental health.  918 
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